State-dependent urothelial barrier engineering for intravesical biomaterials: retention, restoration, and navigation

Intravesical biomaterials operate at an interface whose therapeutic role changes with disease state. In inflammatory bladder disease, urothelial abnormalities can become targets for repair; in non-muscle-invasive bladder cancer (NMIBC), the same interface can restrict access to superficial or deeper therapeutic targets. Existing reviews commonly organize these materials by carrier class or therapeutic modality, but such classifications do not explain why the same property—strong adhesion, increased permeability or prolonged persistence—can be beneficial in one setting and counterproductive in another. Here, we organize the field around three variables: urothelial barrier state, target location or depth, and treatment phase. These variables define three recurring material functions: RETAIN sufficient local exposure, RESTORE a measurable disease-relevant urothelial abnormality, and NAVIGATE to a therapeutic compartment beyond the luminal surface. Evidence from IC/BPS, chemical and radiation cystitis, human bladder pharmacokinetics and emerging NMIBC delivery systems shows that these functions frequently overlap but require different readouts. Structural recovery is not equivalent to functional barrier restoration, and greater tumor accumulation or penetration does not by itself establish cellular uptake or target engagement. A state-dependent view therefore shifts intravesical biomaterial design away from maximizing isolated material properties and toward matching the material–urothelial interaction to a defined therapeutic task, while accounting for normal-urothelial safety and post-treatment recovery.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-12
DOI
https://doi.org/10.3389/fcell.2026.2034298
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

State-dependent urothelial barrier engineering for intravesical biomaterials: retention, restoration, and navigation

Junwei Wang, Miaoyong Ye, Kecheng Lou, Jingyi Zhao
Frontiers in Cell and Developmental Biology
Bladder and Urothelial Cancer Treatments
article

State-dependent urothelial barrier engineering for intravesical biomaterials: retention, restoration, and navigation

Junwei Wang, Miaoyong Ye, Kecheng Lou, Jingyi Zhao
article en

Abstract

Intravesical biomaterials operate at an interface whose therapeutic role changes with disease state. In inflammatory bladder disease, urothelial abnormalities can become targets for repair; in non-muscle-invasive bladder cancer (NMIBC), the same interface can restrict access to superficial or deeper therapeutic targets. Existing reviews commonly organize these materials by carrier class or therapeutic modality, but such classifications do not explain why the same property—strong adhesion, increased permeability or prolonged persistence—can be beneficial in one setting and counterproductive in another. Here, we organize the field around three variables: urothelial barrier state, target location or depth, and treatment phase. These variables define three recurring material functions: RETAIN sufficient local exposure, RESTORE a measurable disease-relevant urothelial abnormality, and NAVIGATE to a therapeutic compartment beyond the luminal surface. Evidence from IC/BPS, chemical and radiation cystitis, human bladder pharmacokinetics and emerging NMIBC delivery systems shows that these functions frequently overlap but require different readouts. Structural recovery is not equivalent to functional barrier restoration, and greater tumor accumulation or penetration does not by itself establish cellular uptake or target engagement. A state-dependent view therefore shifts intravesical biomaterial design away from maximizing isolated material properties and toward matching the material–urothelial interaction to a defined therapeutic task, while accounting for normal-urothelial safety and post-treatment recovery.

Frontiers in Cell and Developmental BiologyVol. 14
The First People's Hospital of Wenling (CN), Second Affiliated Hospital of Zhejiang University (CN), Taizhou University (CN), Taizhou University (CN)
Good health and well-being
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon